GlassScriptPhysician profile
Thomas Lee Ortel
NPI 1003990995
$61,422.14
in general payments reported to CMS, 2019-2025
8 companies · $29K in 2025
The $29K reported for 2025 was more than what 88% of Hematology (Internal Medicine) providers received nationally (typical 2025 total: $1,177).
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,156 · 2020: $15K · 2021: $2,350 · 2023: $11K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $12K · Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,118.00 |
| Travel and Lodging | $11,839.84 |
| Food and Beverage | $198.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| F. Hoffmann-La Roche Ag | $24,108.33 | 2025 | |
| Omeros Corporation | $14,760.00 | 2020 | |
| Sanofi US Services INC. | $11,368.00 | 2023 | |
| Instrumentation Laboratory Company | $5,005.81 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $4,680.00 | 2025 | |
| Diagnostica Stago, INC | $1,500.00 | 2021 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ortel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.